These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2513813)

  • 1. Stimulation of vascular prostacyclin and inhibition of platelet function by oral defibrotide in cholesterol-fed rabbits.
    Löbel P; Schrör K
    Atherosclerosis; 1989 Nov; 80(1):69-79. PubMed ID: 2513813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in platelet reactivity, prostacyclin and thromboxane production after long-term oral defibrotide in healthy and atherosclerotic rabbits.
    Löbel P; Palmér M; Schrör K
    Prog Clin Biol Res; 1987; 242():265-70. PubMed ID: 3313414
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by defibrotide in the platelet perfused heart.
    Löbel P; Schrör K
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):125-30. PubMed ID: 3937058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of defibrotide on aorta and brain malondialdehyde and antioxidants in cholesterol-induced atherosclerotic rabbits.
    Aydemir EO; Duman C; Celik HA; Turgan N; Uysal A; Mutaf I; Habif S; Ozmen D; Nişli N; Bayindir O
    Int J Clin Lab Res; 2000; 30(2):101-7. PubMed ID: 11043504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of prostacyclin synthesis by defibrotide: improved contractile recovery from myocardial "stunning".
    Hohlfeld T; Strobach H; Schrör K
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):108-15. PubMed ID: 1708043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of a thromboxane receptor antagonist (BM 13.505) on platelet hyperreactivity and thromboxane formation in cholesterol-fed rabbits.
    Löbel P; Schrör E; Schrör K
    Biomed Biochim Acta; 1988; 47(10-11):S86-9. PubMed ID: 3073772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K; Löbel P; Steinhagen-Thiessen E
    Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defibrotide's activity on leukocytes and platelets in rabbits with diet-induced atherosclerosis.
    Pescador R; Tettamanti R; Salvetti L; Conto A; Porta R; Mantovani M; Ferro L
    Agents Actions Suppl; 1995; 45():323-7. PubMed ID: 7717197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from post-ischemic acute renal failure in vivo.
    Berti F; Rossoni G; Bianchi G; Alberico P; Tettamanti R; Calvani AB; Mantovani M; Prino G
    Eicosanoids; 1991; 4(4):209-15. PubMed ID: 1789997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial protection by defibrotide--a new strategy for treatment of myocardial infarction?
    Schrör K; Ackermann G; Hohlfeld T; Löbel P; Ney P; Schröder H; Strobach H
    Z Kardiol; 1989; 78 Suppl 6():35-41. PubMed ID: 2559554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral naftidrofuryl prevents platelet hyperreactivity ex vivo and inhibits functional desensitization to prostacyclin in hypercholesterolemic rabbits.
    Weber AA; Hohlfeld T; Strobach H; Schrör K
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):332-8. PubMed ID: 7679170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury.
    Hohlfeld T; Strobach H; Schrör K
    J Pharmacol Exp Ther; 1993 Jan; 264(1):397-405. PubMed ID: 8423539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):679-86. PubMed ID: 3063971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology and mode of action of a new antithrombotic compound: Defibrotide.
    Ulutin ON; Cizmeci G; Balkuv-Ulutin S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):177-80. PubMed ID: 2459016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defibrotide normalizes cardiovascular function hampered by established atherosclerosis in the rabbit.
    Rossoni G; Berti F; Trento F; Cattaneo F; Porta R; Pescador R; Ferro L
    Thromb Res; 2000 Jan; 97(2):29-38. PubMed ID: 10688332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage.
    Thiemermann C; Löbel P; Schrör K
    Am J Cardiol; 1985 Dec; 56(15):978-82. PubMed ID: 3907318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man.
    Coccheri S; Biagi G; Legnani C; Bianchini B; Grauso F
    Eur J Clin Pharmacol; 1988; 35(2):151-6. PubMed ID: 3191933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic oral defibrotide counteracts hypercholesterolemia noxious effects on cardiovascular function in the rabbit.
    Rossoni G; Berti F; Trento F; Cattaneo F; Porta R; Pescador R; Ferro L
    Thromb Res; 1999 Jun; 94(5):327-38. PubMed ID: 10379821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favourable effect of defibrotide in lipid A-induced shock in pigs.
    Hohlfeld T; Bucha E; Nowak G; Brüggener E; Strobach H; Schrör K
    Circ Shock; 1992 Oct; 38(2):122-9. PubMed ID: 1423920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.